Jan Juroška
Europe Guide 2024
Band 4 : Corporate/M&A
Band 4
About
Provided by Jan Juroška
Practice Areas
Jan Juroška is a Partner in tthe Managing Partner of the Prague office, the head of the local and the co-head of the firm-wide M&A, Corporate and Private Equity service line. He has a particular focus on private equity and corporate finance.
Professional Memberships
Czech Bar Association
Languages Spoken
Czech
English
Chambers Review
Europe
Head of department Jan Juroška is appreciated for his experience in advising international private equity funds on acquisitions and investments in the Czech market, enjoying a particular visibility in the manufacturing and technology sectors.
Strengths
Provided by Chambers
"Jan's exceptional legal acumen, combined with a pragmatic and solutions-oriented approach, has consistently delivered outstanding results for our company."
"Jan's exceptional legal acumen, combined with a pragmatic and solutions-oriented approach, has consistently delivered outstanding results for our company."
Articles, highlights and press releases
7 items provided by Kinstellar
Kinstellar advises Kemp Technologies on the acquisition of Flowmon
Kinstellar has successfully advised Kemp Technologies, the leader in powering always-on application experience, on its acquisition of Flowmon, a global network intelligence company.
Kinstellar advises Genesis Growth Equity Fund I on the acquisition of R2B2
Kinstellar has successfully advised Genesis Growth Equity Fund I on its acquisition of R2B2, a key player in programmatic advertising in the Czech Republic.
Kinstellar advises GLP, a leading global investment manager, on a EUR 1 billion multi-jurisdictional
Kinstellar has advised GLP, a leading global investment manager specialising in logistics, real estate, insurance and related technology investments, on the Czech, Slovak and Hungarian law aspects of its acquisition of Goodman Group’s Central and Eastern Europe logistics real real estate portfolio.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s., the Czech Republic, from the Cyrus Poonawalla Group.
Kinstellar advises Genesis Private Equity Fund III on the acquisition of the largest Czech call cent
Kinstellar has successfully advised Genesis Private Equity Fund III (GPEF III) on its acquisition, from Karel Komárek's KKCG investment group, of the largest operator of contact centres in the Czech Republic.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Repub
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.
Kinstellar advises Kemp Technologies on the acquisition of Flowmon
Kinstellar has successfully advised Kemp Technologies, the leader in powering always-on application experience, on its acquisition of Flowmon, a global network intelligence company.
Kinstellar advises Genesis Growth Equity Fund I on the acquisition of R2B2
Kinstellar has successfully advised Genesis Growth Equity Fund I on its acquisition of R2B2, a key player in programmatic advertising in the Czech Republic.
Kinstellar advises GLP, a leading global investment manager, on a EUR 1 billion multi-jurisdictional
Kinstellar has advised GLP, a leading global investment manager specialising in logistics, real estate, insurance and related technology investments, on the Czech, Slovak and Hungarian law aspects of its acquisition of Goodman Group’s Central and Eastern Europe logistics real real estate portfolio.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s., the Czech Republic, from the Cyrus Poonawalla Group.
Kinstellar advises Genesis Private Equity Fund III on the acquisition of the largest Czech call cent
Kinstellar has successfully advised Genesis Private Equity Fund III (GPEF III) on its acquisition, from Karel Komárek's KKCG investment group, of the largest operator of contact centres in the Czech Republic.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Repub
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.
Discover other Lawyers at
Kinstellar
Bulgaria
Central & Eastern Europe
Croatia
Czech Republic
